Brooks Francis, Akram Tahira, Roy Stuart, Pemberton David, Chandatreya Amit
Orthopaedic department, Princess of Wales Hospital, Bridgend, Wales.
Acta Orthop Belg. 2012 Aug;78(4):500-5.
The iForma ConforMIS Interpositional knee device is a recently developed patient specific implant used for the treatment of mild to moderate uni-compartmental osteoarthritis. The benefits over traditional methods of surgical management are: it is less invasive, can be performed as a day procedure and does not limit future options. Bespoke implants are produced from data extracted from MRIs. Twenty-six patients with the iForma ConforMIS interpositional knee implant from November 2007 were retrospectively reviewed. The average age was 54.7 years, The average pre-operative WOMAC score was 37.8 improving to 67.6 post-operatively. Five patients required revision. No dislocations were reported. Our early experience suggests this device is a viable and safe treatment option. However, patient selection plays an important role in the outcome following surgery and long term results should be awaited.
iForma ConforMIS 间置式膝关节装置是一种最近研发的定制植入物,用于治疗轻至中度单髁骨关节炎。与传统手术管理方法相比,其优势在于:侵入性较小,可作为日间手术进行,且不限制未来的选择。定制植入物由从磁共振成像(MRI)中提取的数据制成。对2007年11月至2014年11月期间接受iForma ConforMIS间置式膝关节植入的26例患者进行了回顾性研究。平均年龄为54.7岁,术前WOMAC评分平均为37.8,术后提高到67.6。5例患者需要翻修。未报告脱位情况。我们的早期经验表明,该装置是一种可行且安全的治疗选择。然而,患者选择在术后结果中起着重要作用,应等待长期结果。